 |
The era of prefilled syringes (PFS) has arrived, and while this emerging market brings benefits for patients and healthcare systems, it’s also a compelling business opportunity for pharma developers—one that’s projected to reach $15.7B globally by 2030. But packaging large volume sensitive molecules for self-administration comes with its own set of challenges. Developers must find large-volume packaging solutions that can be safely and effectively used at home and demonstrate safety across their supply chain. This webinar will guide you through overcoming the current challenges in packaging biologics for self-administration, including:
|
